Mostrar o rexistro simple do ítem

dc.contributor.authorCarracedo-Reboredo, Paula
dc.contributor.authorLiñares Blanco, Jose
dc.contributor.authorRodríguez-Fernández, Nereida
dc.contributor.authorCedrón, Francisco
dc.contributor.authorNovoa, Francisco
dc.contributor.authorCarballal, Adrián
dc.contributor.authorMaojo, Víctor
dc.contributor.authorPazos, A.
dc.contributor.authorFernández-Lozano, Carlos
dc.date.accessioned2022-09-28T18:08:50Z
dc.date.available2022-09-28T18:08:50Z
dc.date.issued2021
dc.identifier.citationCarracedo-Reboredo, P., Liñares-Blanco, J., Rodríguez-Fernández, N., Cedrón, F., Novoa, F. J., Carballal, A., Maojo, V., Pazos, A., & Fernandez-Lozano, C. (2021). A review on machine learning approaches and trends in drug discovery. Computational and Structural Biotechnology Journal, 19, 4538–4558.es_ES
dc.identifier.issn2001-0370
dc.identifier.urihttp://hdl.handle.net/2183/31743
dc.description.abstractAbstract: Drug discovery aims at finding new compounds with specific chemical properties for the treatment of diseases. In the last years, the approach used in this search presents an important component in computer science with the skyrocketing of machine learning techniques due to its democratization. With the objectives set by the Precision Medicine initiative and the new challenges generated, it is necessary to establish robust, standard and reproducible computational methodologies to achieve the objectives set. Currently, predictive models based on Machine Learning have gained great importance in the step prior to preclinical studies. This stage manages to drastically reduce costs and research times in the discovery of new drugs. This review article focuses on how these new methodologies are being used in recent years of research. Analyzing the state of the art in this field will give us an idea of where cheminformatics will be developed in the short term, the limitations it presents and the positive results it has achieved. This review will focus mainly on the methods used to model the molecular data, as well as the biological problems addressed and the Machine Learning algorithms used for drug discovery in recent years.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; PI17/01826es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; PI17/01561es_ES
dc.description.sponsorshipXunta de Galicia; Ref. ED431D 2017/16es_ES
dc.description.sponsorshipXunta de Galicia; Ref. ED431D 2017/23es_ES
dc.description.sponsorshipXunta de Galicia; Ref. ED431C 2018/49es_ES
dc.language.isoenges_ES
dc.publisherResearch Network of Computational and Structural Biotechnologyes_ES
dc.relation.urihttps://doi.org/10.1016/j.csbj.2021.08.011es_ES
dc.rights©2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectMachine learninges_ES
dc.subjectDrug discoveryes_ES
dc.subjectCheminformaticses_ES
dc.subjectQSARes_ES
dc.subjectMolecular descriptorses_ES
dc.subjectDeep learninges_ES
dc.titleA review on machine learning approaches and trends in drug discoveryes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleComputational and Structural Biotechnology Journales_ES
UDC.volume19es_ES
UDC.startPage4538es_ES
UDC.endPage4558es_ES
dc.identifier.doihttps://doi.org/10.1016/j.csbj.2021.08.011


Ficheiros no ítem

Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem